Intraductal proliferations of mammary epithelium of the breast form a spectrum that begins with intraductal hyperplasia without atypia (also known as conventional ductal hyperplasia), continues with ...

Hyperplasia is an abnormal but non-cancerous pattern of cell growth within the ducts or lobes of the breast. A hyperplastic breast shows a higher number of cells and layers in the ducts and lobules ...

Gut Microbiota and Benign Prostatic Hyperplasia research highlights new inflammatory pathways and microbiome targets. Learn ...

Combined GLP 1 receptor agonists and progestin therapy reduces endometrial cancer risk and hysterectomy rates in women with benign uterine conditions.

Pseudoangiomatous stromal hyperplasia tumors are rare. In this retrospective study, we evaluated the clinical, radiologic, and pathologic features of pseudoangiomatous stromal hyperplasia tumors and ...

Can adding a GLP-1 to standard progestin therapy for nonmalignant uterine conditions lower women’s risk of developing endometrial cancer?

Endometrial hyperplasia describes a condition in which the lining of the uterus, called the endometrium, becomes too thick. The condition itself is not cancerous; however, it sometimes can lead to ...

Significant progress has been made in the diagnosis and treatment of breast cancer in the last few decades. Screening mammograms have made it possible to detect many tumors at an earlier stage and ...

This page lists all known medications that could potentially lead to 'Sebaceous hyperplasia' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Driven by a growing patient population, rapid adoption of minimally invasive and robotic technologies, increased use of diagnostic-guided focal therapies, and the ongoing dominance of proven ...

This page lists all known medications that could potentially lead to 'Hyperplasia' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...